The mechanical activation of mTOR signaling: An emerging role for late endosome/lysosomal targeting

Journal of Muscle Research and Cell Motility

Volumn 35, Issue 1, 2014, Pages 11-21

  Jacobs, Brittany L ^a   Goodman, Craig A ^a   Hornberger, Troy A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Hypertrophy; Lysosome; Mechanotransduction; MTOR; Protein synthesis; Skeletal muscle

Indexed keywords

MAMMALIA;

TARGET OF RAPAMYCIN KINASE;

ANIMAL; ENDOSOME; HUMAN; METABOLISM; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; ENDOSOMES; HUMANS; MUSCLE, SKELETAL; PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84899471750     PISSN: 01424319     EISSN: 15732657     Source Type: Journal    
DOI: 10.1007/s10974-013-9367-4     Document Type: Review

References (99)

1. Aoki J, Inoue A, Makide K, Saiki N, Arai H (2007) Structure and function of extracellular phospholipase A1 belonging to the pancreatic lipase gene family. Biochimie 89(2):197-204. doi:http://dx.doi.org/10.1016/j.biochi.2006.09. 021 (Pubitemid 46161954)
2. Aspuria PJ, Tamanoi F (2004) The Rheb family of GTP-binding proteins. Cell Signal 16(10):1105-1112. doi:10.1016/j.cellsig.2004.03.019 (Pubitemid 38900513)
3. Avila-Flores A, Santos T, Rincon E, Merida I (2005) Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid. J Biol Chem 280(11): 10091-10099 (Pubitemid 40395861)
4. Ballou LM, Jiang YP, Du G, Frohman MA, Lin RZ (2003) Ca(2 ?)- and phospholipase D-dependent and -independent pathways activate mTOR signaling. FEBS Lett 550(1-3):51-56 (Pubitemid 37281356)
5. Banno Y, Takuwa Y, Yamada M, Takuwa N, Ohguchi K, Hara A, Nozawa Y (2003) Involvement of phospholipase D in insulinlike growth factor-I-induced activation of extracellular signalregulated kinase, but not phosphoinositide 3-kinase or Akt, in Chinese hamster ovary cells. Biochem J 369(Pt 2):363-368. doi:10.1042/BJ20021368BJ20021368 (Pubitemid 36174206)
6. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3(11):1014-1019 (Pubitemid 34428747)
7. Bright NA, Reaves BJ, Mullock BM, Luzio JP (1997) Dense core lysosomes can fuse with late endosomes and are re-formed from the resultant hybrid organelles. J Cell Sci 110(Pt 17):2027-2040 (Pubitemid 27440427)
8. Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B (2000) Rab7: A key to lysosome biogenesis. Mol Biol Cell 11(2):467-480 (Pubitemid 30112158)
9. Cai SL, Tee AR, Short JD, Bergeron JM, Kim J, Shen J, Guo R, Johnson CL, Kiguchi K, Walker CL (2006) Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol 173(2):279-289. doi:10.1083/jcb.200507119
10. Carman GM, Han G-S (2006) Roles of phosphatidate phosphatase enzymes in lipid metabolism. Trends Biochem Sci 31(12):694-699. doi:http://dx.doi.org/10. 1016/j.tibs.2006.10.003 (Pubitemid 44791946)
11. Cleland PJ, Appleby GJ, Rattigan S, Clark MG (1989) Exerciseinduced translocation of protein kinase C and production of diacylglycerol and phosphatidic acid in rat skeletal muscle in vivo. Relationship to changes in glucose transport. J Biol Chem 264(30):17704-17711 (Pubitemid 19279231)
12. Cuervo AM, Dice JF (1996) A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273(5274): 501-503 (Pubitemid 26286451)
13. Dibble Christian C, Elis W, Menon S, Qin W, Klekota J, Asara John M, Finan Peter M, Kwiatkowski David J, Murphy Leon O, Manning Brendan D (2012) TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell 47(4):535-546. doi:http://dx.doi.org/10.1016/j.molcel.2012.06.009
14. Drummond MJ, Fry CS, Glynn EL, Dreyer HC, Dhanani S, Timmerman KL, Volpi E, Rasmussen BB (2009) Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis. J Physiol 587(Pt 7):1535-1546. doi:10.1113/jphysiol.2008.163816
15. Dudgeon WD, Phillips KD, Carson JA, Brewer RB, Durstine JL, Hand GA (2006) Counteracting muscle wasting in HIV-infected individuals. HIV Med 7(5):299-310. doi:10.1111/j.1468-1293.2006.00380.x (Pubitemid 43805690)
16. Eskelinen EL, Tanaka Y, Saftig P (2003) At the acidic edge: Emerging functions for lysosomal membrane proteins. Trends Cell Biol 13(3):137-145 (Pubitemid 36293786)
17. Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J (2001) Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294(5548):1942-1945 (Pubitemid 33101594)
18. Farese RV, Barnes DE, Davis JS, Standaert ML, Pollet RJ (1984) Effects of insulin and protein synthesis inhibitors on phospholipids metabolism, diacylglycerol levels, and pyruvate dehydrogenase activity in BC3H-1 cultured myocytes. J Biol Chem 259(11): 7094-7100 (Pubitemid 14077849)
19. Fearon K, Arends J, Baracos V (2013) Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10(2):90-99. doi:10.1038/nrclinonc.2012.209nrclinonc.2012.209
20. Fitts RH, Riley DR, Widrick JJ (2000) Physiology of a microgravity environment invited review: Microgravity and skeletal muscle. J Appl Physiol 89(2):823-839 (Pubitemid 30637134)
21. Flinn RJ, Yan Y, Goswami S, Parker PJ, Backer JM (2010) The late endosome is essential for mTORC1 signaling. Mol Biol Cell 21(5):833-841. doi:10.1091/mbc.E09-09-0756E09-09-0756
22. Foster DA (2007) Regulation of mTOR by phosphatidic acid? Cancer Res 67(1):1-4 (Pubitemid 46142751)
23. Fujiwara Y, Kikuchi H, Aizawa S, Furuta A, Hatanaka Y, Konya C, Uchida K, Wada K, Kabuta T (2013) Direct uptake and degradation of DNA by lysosomes. degradation of DNA by lysosomes. Autophagy 9(8):1167-1171. doi:10.4161/auto. 2488024880
24. Fukuda M (1991) Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 266(32): 21327-21330 (Pubitemid 121000182)
25. Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, Kozma SC, Hafen E, Bos JL, Thomas G (2003) Insulin activation of Rheb, a mediator of mTOR/S6 K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11(6):1457-1466 (Pubitemid 36776533)
26. Goldberg AL (1968) Protein synthesis during work-induced growth of skeletal muscle. J Cell Biol 36(3):653-658
27. Goldberg AL, Etlinger JD, Goldspink DF, Jablecki C (1975) Mechanism of work-induced hypertrophy of skeletal muscle. Med Sci Sports 7(3):185-198
28. Goodman CA, Miu MH, Frey JW, Mabrey DM, Lincoln HC, Ge Y, Chen J, Hornberger TA (2010) A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy. Mol Biol Cell 21(18):3258-3268. doi:10.1091/mbc.E10-05-0454
29. Goodman CA, Frey JW, Mabrey DM, Jacobs BL, Lincoln HC, You JS, Hornberger TA (2011) The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J Physiol 589(Pt 22):5485-5501. doi:10.1113/jphysiol.2011. 218255
30. Goodman CA, Kotecki JA, Jacobs BL, Hornberger TA (2012) Muscle fiber type-dependent differences in the regulation of protein synthesis. PLoS ONE 7(5):e37890. doi:10.1371/journal.pone.0037890
31. Goodman CA, McNally RM, Hoffmann FM, Hornberger TA (2013) Smad3 induces Atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo. Mol Endocrinol. doi:10.1210/me.2013-1194
32. Ha SH, Kim DH, Kim IS, Kim JH, Lee MN, Lee HJ, Kim JH, Jang SK, Suh PG, Ryu SH (2006) PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals. Cell Signal 18(12):2283-2291 (Pubitemid 44636169)
33. Hornberger TA (2011) Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle. Int J Biochem Cell Biol 43(9):1267-1276. doi:10.1016/j.biocel.2011.05.007
34. Hornberger TA, Chien S (2006) Mechanical stimuli and nutrients regulate rapamycin-sensitive signaling through distinct mechanisms in skeletal muscle. J Cell Biochem 97(6):1207-1216. doi:10.1002/jcb.20671
35. Hornberger TA, Stuppard R, Conley KE, Fedele MJ, Fiorotto ML, Chin ER, Esser KA (2004) Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-,protein kinase B- and growth factor-independent mechanism. Biochem J 380(Pt 3):795-804. doi:10.1042/BJ20040274 (Pubitemid 38850521)
36. Hornberger TA, Chu WK, Mak YW, Hsiung JW, Huang SA, Chien S (2006) The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc Natl Acad Sci USA 103(12):4741-4746. doi:10.1073/pnas.0600678103
37. Hornberger TA, Sukhija KB, Wang XR, Chien S (2007) mTOR is the rapamycin-sensitive kinase that confers mechanically-induced phosphorylation of the hydrophobic motif site Thr(389) in p70(S6 k). FEBS Lett 581(24):4562-4566. doi:10.1016/j.febslet.2007.08.045 (Pubitemid 47418781)
38. Huang J, Manning BD (2008) The TSC1-TSC2 complex: A molecular switchboard controlling cell growth. Biochem J 412(2):179-190. doi:10.1042/bj20080281 (Pubitemid 351758225)
39. Huotari J, Helenius A (2011) Endosome maturation. EMBO J 30(17):3481-3500. doi:10.1038/emboj.2011.286
40. Hurley BF, Hanson ED, Sheaff AK (2011) Strength training as a countermeasure to aging muscle and chronic disease. Sports Med 41(4):289-306. doi:10.2165/11585920-000000000-00000
41. Inoki K, Li Y, Zhu T, Wu J, Guan KL (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4(9):648-657. doi:10.1038/ncb839 (Pubitemid 34993700)
42. Inoki K, Li Y, Xu T, Guan KL (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17(15):1829-1834. doi:10.1101/gad.11100031110003 (Pubitemid 36944560)
43. Izumiya Y, Hopkins T, Morris C, Sato K, Zeng L, Viereck J, Hamilton JA, Ouchi N, LeBrasseur NK, Walsh K (2008) Fast/glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab 7(2):159-172. doi:10.1016/j.cmet.2007.11.003 (Pubitemid 351168553)
44. Jacobs BL, You JS, Frey JW, Goodman CA, Gundermann DM, Hornberger TA (2013) Eccentric contractions increase TSC2 phosphorylation and alter the targeting of TSC2 and mTOR to the lysosome. J Physiol. doi:10.1113/jphysiol. 2013.256339
45. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52(1):80-85 (Pubitemid 38090394)
46. Jewell JL, Russell RC, Guan K-L (2013) Amino acid signaling upstream of mTOR. Nat Rev 14(3):133-139
47. Karnam P, Standaert ML, Galloway L, Farese RV (1997) Activation and translocation of Rho (and ADP ribosylation factor) by insulin in rat adipocytes. Apparent involvement of phosphatidylinositol 3-kinase. J Biol Chem 272(10):6136-6140 (Pubitemid 27118079)
48. Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL (2008) Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 10(8):935-945. doi:10.1038/ncb1753
49. Kubica N, Bolster DR, Farrell PA, Kimball SR, Jefferson LS (2005) Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2Bepsilon mRNA in a mammalian target of rapamycin-dependent manner. J Biol Chem 280(9):7570-7580 (Pubitemid 40349649)
50. Lippincott-Schwartz J, Fambrough DM (1987) Cycling of the integral membrane glycoprotein, LEP100, between plasma membrane and lysosomes: kinetic and morphological analysis. Cell 49(5):669-677
51. Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J (2005a) Rheb binds and regulates the mTOR kinase. Curr Biol 15(8):702-713. doi:10.1016/j.cub.2005.02. 053 (Pubitemid 40599924)
52. Long X, Ortiz-Vega S, Lin Y, Avruch J (2005b) Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J Biol Chem 280(25):23433-23436 (Pubitemid 40884818)
53. Luzio JP, Rous BA, Bright NA, Pryor PR, Mullock BM, Piper RC (2000) Lysosome-endosome fusion and lysosome biogenesis. J Cell Sci 113(Pt 9):1515-1524 (Pubitemid 30312500)
54. Luzio JP, Pryor PR, Bright NA (2007) Lysosomes: fusion and function. Nat Rev Mol Cell Biol 8(8):622-632. doi:10.1038/nrm2217 (Pubitemid 47106614)
55. MacKenzie MG, Hamilton DL, Murray JT, Taylor PM, Baar K (2009) mVps34 is activated following high-resistance contractions. J Physiol 587(Pt 1):253-260. doi:10.1113/jphysiol.2008.159830
56. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 10(1):151-162 (Pubitemid 34876569)
57. Maxfield FR, Yamashiro DJ (1987) Endosome acidification and the pathways of receptor-mediated endocytosis. Adv Exp Med Biol 225:189-198
58. Miyazaki M, McCarthy JJ, Esser KA (2010) Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes. FEBS J 277(9):2180-2191. doi:10.1111/j.1742-4658.2010.07635.x
59. Moylan JS, Reid MB (2007) Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 35(4):411-429. doi:10.1002/mus.20743 (Pubitemid 46542961)
60. Narita M, Young AR, Arakawa S, Samarajiwa SA, Nakashima T, Yoshida S, Hong S, Berry LS, Reichelt S, Ferreira M, Tavare S, Inoki K, Shimizu S (2011) Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 332(6032): 966-970. doi:10.1126/science.1205407science.1205407
61. Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY, Gulati P, Byfield MP, Backer JM, Natt F, Bos JL, Zwartkruis FJ, Thomas G (2005) Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci USA 102(40):14238-14243 (Pubitemid 41429682)
62. O'Neil TK, Duffy LR, Frey JW, Hornberger TA (2009) The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions. J Physiol 587(Pt 14):3691-3701. doi:10.1113/jphysiol.2009.173609
63. Pahor M, Kritchevsky S (1998) Research hypotheses on muscle wasting, aging, loss of function and disability. J Nutr Health Aging 2(2):97-100 (Pubitemid 128695283)
64. Plevin R, Cook SJ, Palmer S, Wakelam MJ (1991) Multiple sources of sn-1,2-diacylglycerol in platelet-derived-growth-factor-stimulated Swiss 3T3 fibroblasts. Evidence for activation of phosphoinositidase C and phosphatidylcholine-specific phospholipase D. Biochem J 279(Pt 2):559-565
65. Potter CJ, Pedraza LG, Xu T (2002) Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4(9):658-665. doi:10.1038/ncb840 (Pubitemid 34993701)
66. Proctor DN, Balagopal P, Nair KS (1998) Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins. J Nutr 128(2 Suppl):351S-355S (Pubitemid 28090378)
67. Rink J, Ghigo E, Kalaidzidis Y, Zerial M (2005) Rab conversion as a mechanism of progression from early to late endosomes. Cell 122(5):735-749. doi:10.1016/j.cell.2005.06.043 (Pubitemid 41242638)
68. Roccio M, Bos JL, Zwartkruis FJ (2006) Regulation of the small GTPase Rheb by amino acids. Oncogene 25(5):657-664. doi:10.1038/sj.onc.1209106 (Pubitemid 43214692)
69. Sa G, Das T (1999) Basic fibroblast growth factor stimulates cytosolic phospholipase A2, phospholipase C-gamma1 and phospholipase D through distinguishable signaling mechanisms. Mol Cell Biochem 198(1-2):19-30 (Pubitemid 29414518)
70. Saito K, Araki Y, Kontani K, Nishina H, Katada T (2005) Novel role of the small GTPase Rheb: Its implication in endocytic pathway independent of the activation of mammalian target of rapamycin. J Biochem 137(3):423-430. doi:10.1093/jb/mvi046 (Pubitemid 40628451)
71. Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E, Carr SA, Sabatini DM (2007) PRAS40 is an insulinregulated inhibitor of the mTORC1 protein kinase. Mol Cell 25(6):903-915. doi:10.1016/j.molcel.2007.03.003 (Pubitemid 46436534)
72. Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar- Peled L, Sabatini DM (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320(5882):1496-1501. doi:10.1126/science.1157535 (Pubitemid 351929429)
73. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM (2010) Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141(2):290-303. doi:10.1016/j.cell.2010. 02.024
74. Sato T, Nakashima A, Guo L, Tamanoi F (2009) Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J Biol Chem 284(19): 12783-12791. doi:10.1074/jbc.M809207200
75. Saucedo LJ, Gao X, Chiarelli DA, Li L, Pan D, Edgar BA (2003) Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat Cell Biol 5(6):566-571. doi:10.1038/ncb996ncb996 (Pubitemid 36781092)
76. Schneede A, Schmidt CK, Holtta-Vuori M, Heeren J, Willenborg M, Blanz J, Domanskyy M, Breiden B, Brodesser S, Landgrebe J, Sandhoff K, Ikonen E, Saftig P, Eskelinen EL (2011) Role for LAMP-2 in endosomal cholesterol transport. J Cell Mol Med 15(2):280-295. doi:10.1111/j.1582-4934.2009.00973.xJCMM973
77. Seguin R, Nelson ME (2003) The benefits of strength training for older adults. Am J Prev Med 25(3 Suppl 2):141-149 (Pubitemid 41116508)
78. Sengupta S, Peterson TR, SabatiniDM(2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40(2):310-322. doi:10.1016/j.molcel.2010.09.026
79. Seymour LW, Shoaibi MA, Martin A, Ahmed A, Elvin P, Kerr DJ, Wakelam MJ (1996) Vascular endothelial growth factor stimulates protein kinase C-dependent phospholipase D activity in endothelial cells. Lab Investig 75(3):427-437 (Pubitemid 26314527)
80. Song J, Jiang YW, Foster DA (1994) Epidermal growth factor induces the production of biologically distinguishable diglyceride species from phosphatidylinositol and phosphatidylcholine via the independent activation of type C and type D phospholipases. Cell Growth Differ 5(1):79-85 (Pubitemid 24256937)
81. Su W, Yeku O, Olepu S, Genna A, Park JS, Ren H, Du G, Gelb MH, Morris AJ, Frohman MA (2009) 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol Pharmacol 75(3):437-446. doi:10.1124/mol.108.053298
82. Sun Y, Fang Y, Yoon MS, Zhang C, Roccio M, Zwartkruis FJ, Armstrong M, Brown HA, Chen J (2008) Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc Natl Acad Sci USA 105(24):8286-8291 (Pubitemid 351904748)
83. TabancayAP,Gau C-L,Machado IMP,Uhlmann EJ,GutmannDH,Guo L, Tamanoi F (2003) Identification of dominant negativemutants of Rheb GTPase and their use to implicate the involvement of human Rheb in the activation of p70S6 K. J Biol Chem 278(41): 39921-39930. doi:10.1074/jbc.M306553200 (Pubitemid 37248556)
84. Takahara T, Hara K, Yonezawa K, Sorimachi H, Maeda T (2006) Nutrient-dependent multimerization of the mammalian target of rapamycin through the N-terminal HEAT repeat region. J Biol Chem 281(39):28605-28614. doi:10.1074/jbc.M606087200 (Pubitemid 44507003)
85. Tang W, Yuan J, Chen X, Gu X, Luo K, Li J, Wan B, Wang Y, Yu L (2006) Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway. J Biochem Mol Biol 39(5):626-635 (Pubitemid 44714544)
86. Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J (2003) Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13(15):1259-1268 (Pubitemid 36953298)
87. van Ijzendoorn SC (2006) Recycling endosomes. J Cell Sci 119(Pt 9): 1679-1681. doi:10.1242/jcs.02948 (Pubitemid 43810994)
88. Vandenburgh HH (1987) Motion into mass: how does tension stimulate muscle growth? Med Sci Sports Exerc 19(5 Suppl): S142-S149
89. Vandenburgh H, Chromiak J, Shansky J, Del Tatto M, Lemaire J (1999) Space travel directly induces skeletal muscle atrophy. Faseb J 13(9):1031-1038 (Pubitemid 29249728)
90. Veverka V, Crabbe T, Bird I, Lennie G, Muskett FW, Taylor RJ, Carr MD (2008) Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: Compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR. Oncogene 27(5):585-595 (Pubitemid 351158903)
91. Wang X, Devaiah SP, Zhang W, Welti R (2006) Signaling functions of phosphatidic acid. Prog Lipid Res 45(3):250-278
92. Yoon MS, Du G, Backer JM, Frohman MA, Chen J (2011a) Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway. J Cell Biol 195(3):435-447. doi:10.1083/jcb.201107033
93. Yoon MS, Sun Y, Arauz E, Jiang Y, Chen J (2011b) Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect. J Biol Chem 286(34):29568-29574. doi:10.1074/jbc.M111.262816
94. You JS, Frey JW, Hornberger TA (2012) Mechanical stimulation induces mTOR signaling via an ERK-independent mechanism: Implications for a direct activation of mTOR by phosphatidic acid. PLoS ONE 7(10):e47258. doi:10.1371/journal.pone.0047258
95. Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D (2003) Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 5(6):578-581. doi:10.1038/ncb999ncb999 (Pubitemid 36781094)
96. Zhang HH, Huang J, Duvel K, Boback B, Wu S, Squillace RM, Wu CL, Manning BD (2009) Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS ONE 4(7):e6189. doi:10.1371/journal.pone.0006189
97. Zhao K, Zhou H, Zhao X, Wolff DW, Tu Y, Liu H, Wei T, Yang F (2012) Phosphatidic acid mediates the targeting of tBid to induce lysosomal membrane permeabilization and apoptosis. J Lipid Res 53(10):2102-2114. doi:10.1194/jlr.M027557
98. Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM (2011) mTORC1 senses lysosomal amino acids through an insideout mechanism that requires the vacuolar H(+)-ATPase. Science 334(6056):678-683. doi:10.1126/science. 1207056334/6056/678
99. Zou J, Zhou L, Du XX, Ji Y, Xu J, Tian J, Jiang W, Zou Y, Yu S, Gan L, Luo M, Yang Q, Cui Y, Yang W, Xia X, Chen M, Zhao X, Shen Y, Chen PY, Worley PF, Xiao B (2011) Rheb1 is required for mTORC1 and myelination in postnatal brain development. Dev Cell 20(1):97-108. doi:10.1016/j.devcel.2010.11.020